Module

Timing of Antiretroviral Initiation in Treatment-Naive Patients

Source: When to Start, What to Use: A Master Class in the Use of First-Line Antiretroviral Therapy

Timing of Antiretroviral Initiation in Treatment-Naive Patients

Faculty:

Keith Henry, MD

CME CREDIT INFORMATION

Release Date: 12/11/07

Expiration Date: 12/10/08

Physicians: maximum of 1.0 AMA PRA Category 1 Credit™

Registered Nurses: 1.0 Nursing CE credit

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Summarize the current DHHS recommendations on when to start antiretroviral therapy in treatment-naive HIV-infected individuals
Describe data from observational cohorts that have suggested benefits to initiating therapy at CD4+ cell counts > 350 cells/mm³
Discuss the potential risks and benefits of earlier initiation of antiretroviral therapy

Topics covered include:

Introduction
Historical Overview
Updated DHHS Guidelines on When to Start Antiretroviral Therapy
Established and Emerging Goals of Antiretroviral Therapy
The Potential Benefits of Early Treatment
The Potential Risks of Early Treatment
When to Start Antiretroviral Therapy: The Role of the Patient
When to Start Antiretroviral Therapy: The Role of the Healthcare System
Conclusions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.